Devin B. Lowe Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology Texas Tech University Health Sciences Center Biography Publications Institution JoVE Articles Devin B. Lowe has not added a biography. If you are Devin B. Lowe and would like to personalize this page please email our Author Liaison for assistance. Publications Monitoring Antigen-specific T Cell Responses Using Real-time PCR Methods in Molecular Biology (Clifton, N.J.). 2014 | Pubmed ID: 25149303 Dasatinib Promotes the Expansion of a Therapeutically Superior T-cell Repertoire in Response to Dendritic Cell Vaccination Against Melanoma Oncoimmunology. Jan, 2014 | Pubmed ID: 24734217 The Role of Gamma Interferon in DNA Vaccine-induced Tumor Immunity Targeting Simian Virus 40 Large Tumor Antigen Cancer Immunology, Immunotherapy : CII. Feb, 2013 | Pubmed ID: 22926061 Shock Block for Improved Immunotherapy Oncoimmunology. Nov, 2012 | Pubmed ID: 23243617 Combined Vaccine+axitinib Therapy Yields Superior Antitumor Efficacy in a Murine Melanoma Model Melanoma Research. Jun, 2012 | Pubmed ID: 22504156 Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8(+) T Cell-dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice Journal of Immunology (Baltimore, Md. : 1950). Feb, 2012 | Pubmed ID: 22246626 Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity in Vivo Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2012 | Pubmed ID: 22215017 Chronic Inflammation and Immunologic-based Constraints in Malignant Disease Immunotherapy. Oct, 2011 | Pubmed ID: 21995576 CD4+ T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA Journal of Virology. Jul, 2011 | Pubmed ID: 21593176 Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens Molecular Therapy : the Journal of the American Society of Gene Therapy. Apr, 2011 | Pubmed ID: 21189473 Vaccines and Immunotherapeutics for the Treatment of Malignant Disease Clinical & Developmental Immunology. 2010 | Pubmed ID: 20936120 Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen Journal of Virology. Oct, 2010 | Pubmed ID: 20668083 Tumor Immunity Against a Simian Virus 40 Oncoprotein Requires CD8+ T Lymphocytes in the Effector Immune Phase Journal of Virology. Jan, 2010 | Pubmed ID: 19889780 A NOD/SCID Tumor Model for Human Ovarian Cancer That Allows Tracking of Tumor Progression Through the Biomarker Sp17 Journal of Immunological Methods. Apr, 2007 | Pubmed ID: 17336323 Fc Gamma Receptors Play a Dominant Role in Protective Tumor Immunity Against a Virus-encoded Tumor-specific Antigen in a Murine Model of Experimental Pulmonary Metastases Journal of Virology. Feb, 2007 | Pubmed ID: 17108042 DNA Vaccines: Successes and Limitations in Cancer and Infectious Disease Journal of Cellular Biochemistry. May, 2006 | Pubmed ID: 16440328 In Vitro Simian Virus 40 Large Tumor Antigen Expression Correlates with Differential Immune Responses Following DNA Immunization Virology. Feb, 2005 | Pubmed ID: 15661138 Anti-idiotype Responses Abrogate Anti-CD4-induced Tolerance to a Tumor-specific Antigen and Promote Systemic Tumor Immunity Cancer Immunology, Immunotherapy : CII. Nov, 2004 | Pubmed ID: 15156293 Upptäckt av HLA-antigen Biomarkers i bröstcancer Använda Label fria Biosensor Teknik Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
Upptäckt av HLA-antigen Biomarkers i bröstcancer Använda Label fria Biosensor Teknik Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
